Molecular Epidemiology of Measles, Mumps, and Rubella
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 175
Special Issue Editors
Interests: molecular epidemiology of viruses; HPV epidemiology; vaccine preventable diseases
Interests: molecular epidemiology of measles, mumps and rubella viruses; next generation sequencing; role of rubella virus in chronic lesions; development of lab methodologies to improve global measles and rubella surveillance such as point of care tests and lower cost next generation sequencing platforms
Special Issue Information
Dear Colleagues,
Vaccination against measles, mumps and rubella has drastically decreased the incidence, mortality and morbidity of these grave infectious diseases. Several initiatives have been undertaken by individual countries, WHO, the Measles & Rubella Partnership, and others to eradicate measles and rubella. Nonetheless, high quality epidemiological and laboratory surveillance is necessary to confirm the interruption or near elimination of endemic transmission in countries, and to control transmission in endemic countries. For mumps, though global elimination is not yet the focus, countries with high vaccine uptake have experienced a significant reduction in cases and transmission of mumps. However, vaccine immunity waning is strongly suggested by recent mumps outbreaks that predominantly affect vaccinated young adults.
Along with classic epidemiology, genotyping and sequence analysis are powerful tools for defining measles, mumps and rubella epidemiology, and for documenting interruption of endemic transmission. To ensure a drastic decrease in genetic diversity of these viruses, as we approach elimination, more discriminating genotyping tools, such as extensive sequence analysis of outbreaks, whole genome sequencing, and bioinformatics analysis are required to track endemic and non-endemic transmission.
The aim of this Special Issue of Viruses is to collate papers that explore the molecular approaches used in the global surveillance and epidemiology of measles, mumps and rubella, with varied methodologies to characterise outbreaks and define the transmission of these vaccine-preventable viruses.
Dr. Alberto Severini
Guest Editor
Joanne Hiebert
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- measles
- mumps
- rubella
- molecular epidemiology
- next generation sequencing
- analysis of outbreaks
- vaccine preventable diseases
